Related references
Note: Only part of the references are listed.Distinct Patterns of Amyloid-Dependent Tau Accumulation in Lewy Body Diseases
Seung Ha Lee et al.
MOVEMENT DISORDERS (2018)
Cerebrospinal Fluid, Plasma, and Saliva in the BioFIND Study: Relationships Among Biomarkers and Parkinson's Disease Features
Jennifer G. Goldman et al.
MOVEMENT DISORDERS (2018)
Can neuroimaging predict dementia in Parkinson's disease?
Juliette H. Lanskey et al.
BRAIN (2018)
Clinical and Imaging Correlates of Amyloid Deposition in Dementia With Lewy Bodies
Paul C. Donaghy et al.
MOVEMENT DISORDERS (2018)
CSF tau and β-amyloid predict cerebral synucleinopathy in autopsied Lewy body disorders
David J. Irwin et al.
NEUROLOGY (2018)
Associations Between Tau, beta-Amyloid, and Cognition in Parkinson Disease
Joseph R. Winer et al.
JAMA NEUROLOGY (2018)
Utilizing the Centiloid scale in cross-sectional and longitudinal PiB PET studies
Yi Su et al.
NEUROIMAGE-CLINICAL (2018)
Longitudinal Alterations of Alpha-Synuclein, Amyloid Beta, Total, and Phosphorylated Tau in Cerebrospinal Fluid and Correlations Between Their Changes in Parkinson's Disease
Mahsa Dolatshahi et al.
FRONTIERS IN NEUROLOGY (2018)
Brain Amyloid Contribution to Cognitive Dysfunction in Early-Stage Parkinson's Disease: The PPMI Dataset
Eleonora Fiorenzato et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Practical Bayesian model evaluation using leave-one-out cross-validation and WAIC
Aki Vehtari et al.
STATISTICS AND COMPUTING (2017)
18F-Florbetaben PET beta-amyloid binding expressed in Centiloids
Christopher C. Rowe et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Extremely Low Prevalence of Amyloid Positron Emission Tomography Positivity in Parkinson's Disease without Dementia
Kyoko Mashima et al.
EUROPEAN NEUROLOGY (2017)
brms: An R Package for Bayesian Multilevel Models Using Stan
Paul-Christian Buerkner
JOURNAL OF STATISTICAL SOFTWARE (2017)
In Vivo Cortical Tau in Parkinson's Disease Using 18F-AV-1451 Positron Emission Tomography
Allan K. Hansen et al.
MOVEMENT DISORDERS (2017)
Cognitive decline in Parkinson disease
Dag Aarsland et al.
NATURE REVIEWS NEUROLOGY (2017)
Optimized classification of 18F-Florbetaben PET scans as positive and negative using an SUVR quantitative approach and comparison to visual assessment
Santiago Bullich et al.
NEUROIMAGE-CLINICAL (2017)
Caregiver burden is increased in Parkinson's disease with mild cognitive impairment (PD-MCI)
Ann J. Jones et al.
TRANSLATIONAL NEURODEGENERATION (2017)
Regional brain amyloid-β accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia
Rizwan S. Akhtar et al.
PLOS ONE (2017)
Defining imaging biomarker cut points for brain aging and Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2017)
Partial-Volume Effect Correction Improves Quantitative Analysis of 18F-Florbetaben β-Amyloid PET Scans
Michael Rullmann et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Striatal and Cortical -Amyloidopathy and Cognition in Parkinson's Disease
Neha Shah et al.
MOVEMENT DISORDERS (2016)
Alzheimer's disease: the amyloid hypothesis on trial
Judith R. Harrison et al.
BRITISH JOURNAL OF PSYCHIATRY (2016)
Presence of cerebral amyloid modulates phenotype and pattern of neurodegeneration in early Parkinson's disease
Corey T. McMillan et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Impact of Training Method on the Robustness of the Visual Assessment of 18F-Florbetaben PET Scans: Results from a Phase-3 Study
John Seibyl et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases
Stephen N. Gomperts et al.
JAMA NEUROLOGY (2016)
Different PD-MCI criteria and risk of dementia in Parkinson's disease: 4-year longitudinal study
Kyla-Louise Wood et al.
NPJ PARKINSONS DISEASE (2016)
Cerebrospinal Fluid Amyloid β1-42, Tau, and Alpha-Synuclein Predict the Heterogeneous Progression of Cognitive Dysfunction in Parkinson's Disease
Ju-Hee Kang
JOURNAL OF MOVEMENT DISORDERS (2016)
The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET
William E. Klunk et al.
ALZHEIMERS & DEMENTIA (2015)
Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study
Osama Sabri et al.
ALZHEIMERS & DEMENTIA (2015)
Prevalence of Amyloid PET Positivity in Dementia Syndromes A Meta-analysis
Rik Ossenkoppele et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Amyloid deposition in Parkinson's disease and cognitive impairment: A systematic review
Myria Petrou et al.
MOVEMENT DISORDERS (2015)
The case for rejecting the amyloid cascade hypothesis
Karl Herrup
NATURE NEUROSCIENCE (2015)
The amyloid hypothesis, time to move on: Amyloid is the downstream result, not cause, of Alzheimer's disease
David A. Drachman
ALZHEIMERS & DEMENTIA (2014)
The Significance of α-Synuclein, Amyloid-β and Tau Pathologies in Parkinsn's Disease Progression and Related Dementia
Yaroslau Compta et al.
NEURODEGENERATIVE DISEASES (2014)
Permutation inference for the general linear model
Anderson M. Winkler et al.
NEUROIMAGE (2014)
PET Quantification of 18F-Florbetaben Binding to β-Amyloid Deposits in Human Brains
Georg A. Becker et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies
David J. Irwin et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia
Stephen N. Gomperts et al.
NEUROLOGY (2013)
Microglia, Amyloid, and Glucose Metabolism in Parkinson's Disease with and without Dementia
Paul Edison et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Combined dementia-risk biomarkers in Parkinson's disease: A prospective longitudinal study
Yaroslau Compta et al.
PARKINSONISM & RELATED DISORDERS (2013)
Pathologic Accumulation of α-Synuclein and Aβ in Parkinson Disease Patients With Dementia
Paul T. Kotzbauer et al.
ARCHIVES OF NEUROLOGY (2012)
Heterogenous mechanisms of mild cognitive impairment in Parkinson's disease
Kurt Jellinger
JOURNAL OF NEURAL TRANSMISSION (2012)
Brain amyloid and cognition in Lewy body diseases
Stephen N. Gomperts et al.
MOVEMENT DISORDERS (2012)
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
Irene Litvan et al.
MOVEMENT DISORDERS (2012)
Aβ-amyloid deposition in patients with Parkinson disease at risk for development of dementia
Myria Petrou et al.
NEUROLOGY (2012)
Grey matter volume correlates of cerebrospinal markers of Alzheimer-pathology in Parkinson's disease and related dementia
Yaroslau Compta et al.
PARKINSONISM & RELATED DISORDERS (2012)
Presence of Striatal Amyloid Plaques in Parkinson's Disease Dementia Predicts Concomitant Alzheimer's Disease: Usefulness for Amyloid Imaging
Brittany N. Dugger et al.
JOURNAL OF PARKINSONS DISEASE (2012)
Longitudinal Assessment of A beta and Cognition in Aging and Alzheimer Disease
Victor L. Villemagne et al.
ANNALS OF NEUROLOGY (2011)
pROC: an open-source package for R and S plus to analyze and compare ROC curves
Xavier Robin et al.
BMC BIOINFORMATICS (2011)
Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?
Yaroslau Compta et al.
BRAIN (2011)
Amyloid-β and τ biomarkers in Parkinson's disease-dementia
Mariateresa Buongiorno et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Heterogeneous neuropathological findings in Parkinson's disease with mild cognitive impairment
Charles H. Adler et al.
ACTA NEUROPATHOLOGICA (2010)
CSF amyloid β 1-42 predicts cognitive decline in Parkinson disease
A. Siderowf et al.
NEUROLOGY (2010)
Parkinson Disease With Dementia Comparing Patients With and Without Alzheimer Pathology
Marwan N. Sabbagh et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2009)
Cortical α-synuclein load is associated with amyloid-β plaque burden in a subset of Parkinson's disease patients
Tammaryn Lashley et al.
ACTA NEUROPATHOLOGICA (2008)
Striatal β-amyloid deposition in Parkinson disease with dementia
Michail E. Kalaitzakis et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
Mariese A. Hely et al.
MOVEMENT DISORDERS (2008)
Imaging amyloid deposition in Lewy body diseases
S. N. Gomperts et al.
NEUROLOGY (2008)
Clinical diagnostic criteria for dementia associated with Parkinson's disease
Murat Emre et al.
MOVEMENT DISORDERS (2007)
Hypothalamic abnormalities in schizophrenia: Sex effects and genetic vulnerability
Jill M. Goldstein et al.
BIOLOGICAL PSYCHIATRY (2007)
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest
Rahul S. Desikan et al.
NEUROIMAGE (2006)
Decreased volume of left and total anterior insular lobule in schizophrenia
N Makris et al.
SCHIZOPHRENIA RESEARCH (2006)
Structural brain magnetic resonance imaging of limbic and thalamic volumes in pediatric bipolar disorder
JA Frazier et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review
Evita Evangelia Christou et al.
SEMINARS IN OPHTHALMOLOGY
Share Paper
